Faruk Skenderi, MD, PhD

Pathologist, Assistant Professor

Affiliations

Department of Pathology, Medical School, Sarajevo School of Science and Technology
E-mail: faruk.skenderi@biomolbiomed.com

EDUCATION AND TRAINING

  • Doctor of Science (Ph.D.), Pathology, University of Zagreb School of Medicine, Croatia (2021)
  • Pathologist, Board-certified (2017)
  • Pathology Resident, University of Sarajevo Clinical Center (2012 – 2017)
  • Master of Science (MSc), University of Sarajevo, Bosnia and Herzegovina and University of Rijeka, Croatia (2009 – 2011)
  • Research fellow, Center for Proteomics, University of Rijeka, Croatia (2009 – 2010)
  • Medical Doctor (MD), University of Sarajevo Faculty of Medicine, Bosnia and Herzegovina (2007)

PROFESSIONAL EXPERIENCE

  • Consultant Pathologist, Precision Diagnostics Lab, (2025 – present)
    • Breast pathology, Molecular pathology
  • CEO and consultant, GenoLab Ltd. (2021- present)
    • Providing precision medicine services and consultations
  • Head of Pathology Lab, UniMed, Sarajevo School of Science and Technology (2023 – 2025)
    • Overseeing diagnostic pathology service and laboratory management
  • Pathologist, University of Sarajevo Clinical Center (2017 – 2021)
    • Specialized in tissue and biomarker analysis of breast lesions as a member of a multidisciplinary breast cancer treatment team
  • Pathology resident, University of Sarajevo Clinical Center (2012-2017)

TEACHING EXPERIENCE

  • Assistant professor of Pathology, Medical School, Sarajevo School of Science and Technology (2023 – present)
    • Teaching Pathology to medical students
  • Lecturer, University of Sarajevo Faculty of Health Sciences (2015 – 2022)
    • Undergraduate courses in Pathology and Pathophysiology, Histopathology techniques, Morphology methods for students of Health Sciences
  • Lecturer, University of Sarajevo Medical Faculty (2017 – 2019)
    • Undergraduate courses in Pathology for medical school students
  • Teaching and research assistant, University of Sarajevo Medical Faculty (2007-2011)
    • Courses in Biochemistry for medical school students

EDITORIAL AND LEADERSHIP ROLES

  • Managing Editor, Biomolecules and Biomedicine (formerly BJBMS) (2014 – present)
  • Associate Editor, BMC Cancer Cell International (2019 – 2020)
  • President, Association of Pathologists and Cytologists of FBIH (2019 – present)

WORKSHOPS AND SYMPOSIA

  • Organizer, Bryan Warren School of Pathology (2012 – present)
  • Organizer, Bosnian Turkish School of Cytopathology (2016 – present)

SKILLS

  • Diagnostic and research histopathology (breast pathology, kidney pathology)
  • Diagnostic and research immunohistochemistry (IHC) and In situ hybridization (ISH)
  • Hybridoma and monoclonal antibody technology
  • Cell lines, Flow cytometry, PCR, Western blot, ELISA

MEMBERSHIPS

  • United States and Canadian Academy of Pathology (USCAP)
  • European Society of Pathology (ESP)
  • International Society for Urological Pathology (ISUP)
  • Association of Pathologists and Cytologists of FBIH
  • Association of Basic Medical Sciences of FBIH

AWARDS

  • USCAP Global Partner award (2021, 2019)
  • BDIAP Nermin Durakovic award (2024, 2018, 2014)
  • Marie Curie Actions, Early-stage research fellow (2009 – 2010)
  • Erasmus Mundus Basileus fellowship (2009)
  • Dean’s award for excellence (2006)

PEER REVIEWER

INVITED TALKS

  • Monoclonal antibodies in the treatment of malignant and infectious diseases. Postgraduate course: Modern vaccines in medicine and vaccination. 24 April 2025, Mostar, Bosnia and Herzegovina
  • From 0-100 tests/year in 36 months – a case study from Bosnia and Herzegovina. Distributors meeting. 19-20 May, Prague, Czech Republic
  • Preparing pathologists for the digital and molecular era. Ljudevit Jurak symposium, 06-07 June 2025, Zagreb, Croatia
  • Navigating the process: A guide to publishing a scientific paper. Regional symposium of young endocrinologists, 02-04 June 2023, Sarajevo, Bosnia and Herzegovina
  • Production and application of monoclonal antibodies in the treatment of malignant and infectious diseases. Postgraduate course: Modern vaccines in medicine and vaccination. 24 April 2023, Mostar, Bosnia and Herzegovina
  • Scientific publishing: How to choose the ideal journal for your paper? Symposium: Question for science: Vaccination or smart drugs? 24 April 2023, Mostar, Bosnia and Herzegovina
  • Novelties in pediatric pathology: transition from tissue to molecular diagnostics. 3rd Congress of the International Association for Preventive Paediatrics, 2-4 December 2022, Belgrade, Serbia
  • How to write and publish a scientific paper. 3rd Congress of the International Association for Preventive Paediatrics, 2-4 December 2022, Belgrade, Serbia
  • The role of the PIK3CA mutation in breast cancer from a pathologist’s perspective. 10 December 2020, Webinar
  • Mammaprint and Blueprint from the pathologist’s perspective. 30 November 2020, Webinar
  • PD-L1 testing experience in Bosnia and Herzegovina. 20 October 2020, Webinar
  • Defeating the remaining HER2-positive breast cancer. 6 August 2020, Webinar
  • Triple negative breast carcinoma (TNBC). From triple-negative to PD-L1 positive breast cancer, 16 June 2020, Webinar
  • Pseudojournals: why bother? Round table: Medical journals publishing; current state and perspectives, Montenegrin Academy of Sciences and Arts, 25 October 2019, Podgorica, Montenegro
  • PDL1 expression and associations in tumor biology. Young Oncologist Academy on Immunotherapy, 25-27 May, 2018, Tarcin, Bosnia and Herzegovina
  • The importance of the pre-analytical phase in the pathological molecular evaluation of breast cancer. Symposium on Breast cancer and treatment modalities, 27 October 2017, Clinical Center University of Sarajevo, Sarajevo Bosnia and Herzegovina
  • Neuroendocrine carcinoma of the breast: A retrospective review. 3rd Congress of Pathologists of Bosnia and Herzegovina, 2-3 November 2016, Sarajevo, Bosnia and Herzegovina
  • Warthin-like papillary renal cell carcinoma with prominent lymphocytic infiltrate. XXXI International Congress of the International Academy of Pathology and the 28th Congress of the European Society of Pathology. 25-29 September 2016, Cologne, Germany
  • Isolation and characterization of monoclonal antibodies specific to the m74 gene product of mouse cytomegalovirus. 1st Symposium of the Geneticist of Bosnia and Herzegovina. 17-18 February 2011, Sarajevo, Bosnia and Herzegovina

PUBLICATIONS

  1. Gatalica Z, Rose I, Skenderi F, Kuzmova N, Beslija S, Ceric T, Marijanovic I, Kurtishi I, Vranic S. Abstract P1-11-17: High Tumor-Infiltrating Lymphocyte Levels Correlate with High MammaPrint® Recurrence Risk in Early-Stage Breast Carcinomas. Clinical Cancer Research 2025;31(12_Supplement):P1-11-17-P1-11-17. doi:10.1158/1557-3265.sabcs24-p1-11-17
  2. Skenderi F, Babu GR, Glamoclija U, Veledar E, Gatalica Z, Lamovec J, Vranic S. Acinic Cell Carcinoma of the Breast: A Population‐Based Clinicopathologic Study. Cancer Reports 2025;8(10):e70357. doi:10.1002/cnr2.70357 PubMed
  3. Skenderi F, Mlaco L, Mujic M, Vranic S. From BJBMS to Biomolecules and Biomedicine: A new chapter. Biomol Biomed 2025;25(10):2148-2150. doi:10.17305/bb.2025.12867 PubMed
  4. Begagić E, Skenderi F, Vranić S. The role of reviewers in the era of systematic reviews and meta-analysis: A practical guide for researchers. Biomol Biomed 2025;26(1):40-50. doi:10.17305/bb.2025.12979 PubMed
  5. Skenderi F, Babu GR, Glamoclija U, Veledar E, Gatalica Z, Lamovec J, Vranic S. Acinic Cell Carcinoma of The Breast: A Population-Based Clinicopathologic Study. Research Square 2024. doi:10.21203/rs.3.rs-4450431/v1
  6. Gatalica Z, Kuzmova N, Rose I, Ulamec M, Peric-Balja M, Skenderi F, Vranic S. The assessment of tumor-infiltrating lymphocytes in invasive apocrine carcinoma of the breast in relation to the HER2 status. Biomol Biomed 2024;24(2):256-261. doi:10.17305/bb.2023.9868 PubMed
  7. Mujić M, Vranić S, Skenderi F. Bosnian Journal of Basic Medical Sciences becomes Biomolecules and Biomedicine. Biomol Biomed 2023;23(1):1. doi:10.17305/bjbms.2022.8686 PubMed
  8. Tomic K, Karan Krizanac D, Skenderi F, Krpina K, Carapina Bilic A, Galic K, Gatalica Z, Vranic S. Comprehensive genomic profiling of a metastatic small cell lung carcinoma with a complete and long-term response to atezolizumab: A case report. Respiratory Medicine Case Reports 2023;45:101920. doi:10.1016/j.rmcr.2023.101920 PubMed
  9. Alaghehbandan R, Agaimy A, Ali L, Alvarado-Cabrero I, Amin MB, Boudova L, Caliò A, Comperat EM, Damjanov I, Daum O, Farcas M, Gatalica Z, Gill AJ, Hartmann A, Hayes MM, et al.. A tribute to Prof. Ondrej Hes, MD, PhD (1968–2022). Modern Pathology 2022;35(12):2023-2024. doi:10.1038/s41379-022-01159-8 PubMed
  10. Ajkunic A, Skenderi F, Shaker N, Akhtar S, Lamovec J, Gatalica Z, Vranic S. Acinic cell carcinoma of the breast: A comprehensive review. The Breast 2022;66:208-216. doi:10.1016/j.breast.2022.10.012 PubMed
  11. Mašić S. Correlation of expression of TGF-beta and MMP2 between prostatic adenocarcinoma and adjacent unaffected parenchyma. ACC 2022;61(Suppl 3):9-14. doi:10.20471/acc.2022.61.s3.1 PubMed
  12. Skenderi F, Alahmad MAM, Tahirovic E, Alahmad YM, Gatalica Z, Vranic S. HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Treatment and Outcome. Research Square 2022. doi:10.21203/rs.3.rs-1280152/v1
  13. Kolar J, Llaurado AF, Ulamec M, Skenderi F, Perez-Montiel D, Alvarado-Cabrero I, Bulimbasic S, Sperga M, Tretiakova M, Osunkoya AO, Rogala J, Comperat E, Gal V, Dunatov A, Pivovarcikova K, et al.. Histologic diversity in chromophobe renal cell carcinoma does not impact survival outcome: A comparative international multi-institutional study. Annals of Diagnostic Pathology 2022;60:151978. doi:10.1016/j.anndiagpath.2022.151978 PubMed
  14. Ibisevic N, Bajrovic J, Saranovic E, Spiritovic D, Skenderi F, Vranic S. A Giant, Complex Fibroepithelial Tumor of the Breast: Borderline Phyllodes Tumor Combined with Tubular Adenoma - a Rare Clinical Presentation of a Fibroepithelial Tumor of the Breast. ama 2021;50(1):218. doi:10.5644/ama2006-124.337 PubMed
  15. Zvizdic D, Bulja D, Sidran A, Skenderi F, Zvizdic Z, Vranic S. Isolated deep orbital hemangioma treated successfully with oral propranolol in a 2-month-old infant: Case report with literature review. American Journal of Ophthalmology Case Reports 2021;22:101095. doi:10.1016/j.ajoc.2021.101095 PubMed
  16. Kruslin B, Gatalica Z, Hes O, Skenderi F, Miettinen M, Contreras E, Xiu J, Ellis M, Florento E, Vranic S, Swensen J. TERT Gene Fusions Characterize a Subset of Metastatic Leydig Cell Tumors. Clinical Genitourinary Cancer 2021;19(4):333-338. doi:10.1016/j.clgc.2021.02.002 PubMed
  17. Zvizdic Z, Selimovic M, Mesic A, Anic D, Misanovic V, Skenderi F, Vranic S. Unexpected adrenal pheochromocytoma associated with a generalized tonic-clonic seizure in a prepubertal boy A case report. Medicine (Baltimore) 2021;100(4):e24303. doi:10.1097/md.0000000000024303 PubMed
  18. Bešlija S, Gojković Z, Cerić T, Mekić Abazović A, Marijanović I, Vranić S, Mustedanagić–Mujanović J, Skenderi F, Rakita I, Guzijan A, Koprić D, Humačkić A, Trokić D, Alidžanović J, Efendić A, et al.. 2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina.. Bosn J of Basic Med Sci 2020;21(2):120-135. doi:10.17305/bjbms.2020.4846 PubMed
  19. Zvizdic Z. A case of extra-adrenal retroperitoneal ganglioneuroma in a 9-year-old female: A new case report with a comprehensive literature review. Central Eur J Paed 2020;16(2):140-146. doi:10.5457/p2005-114.270
  20. Zvizdic Z. A free terminal ileal perforation as the presenting sign of crohn’s disease in an adolescent female. CEJoP 2020;16(1):83-84. doi:10.5457/p2005-114.259
  21. Zvizdic Z, Summers A, Moinuddin Z, Van Dellen D, Pasic-Sefic I, Skenderi F, Vranic S, Augustine T. A Successful Treatment of Encapsulating Peritoneal Sclerosis in an Adolescent Boy on Long-term Peritoneal Dialysis: A Case Report. Prague Med. Rep. 2020;121(4):254-261. doi:10.14712/23362936.2020.22 PubMed
  22. Additional file 1 of Co-presence of human papillomaviruses and Epstein–Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients. 2020. doi:10.6084/m9.figshare.12757424.v1
  23. Additional file 2 of Co-presence of human papillomaviruses and Epstein–Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients. 2020. doi:10.6084/m9.figshare.12757427
  24. Gupta I, Al-Thawadi HA, Skenderi F, Malki MI, Vranic S, Al-Moustafa AE. co incidence of human papillomaviruses and epstein barr virus is associated with advanced tumor stage a tissue microarray study of head and neck cancers. University of the Future: Re-Imagining Research and Higher Education 2020. doi:10.29117/quarfe.2020.0122
  25. Al-Thawadi H, Gupta I, Jabeen A, Skenderi F, Aboulkassim T, Yasmeen A, Malki MI, Batist G, Vranic S, Al MoustafaAE. Co-presence of human papillomaviruses and Epstein-Barr virus is linked with advanced tumor stage: A tissue microarray study in head and neck cancer patients. Cancer Cell Int 2020;20:361. doi:10.6084/m9.figshare.c.5081564 PubMed
  26. Zvizdic Z, Bukvic M, Murtezic S, Skenderi F, Vranic S. Giant Paratubal Serous Cystadenoma in an Adolescent Female: Case Report and Literature Review.. Journal of Pediatric and Adolescent Gynecology 2020;33(4):438-440. doi:10.1016/j.jpag.2020.03.010 PubMed
  27. Vranic S, Skenderi F, Beslagic V, Gatalica Z. Glycogen-rich Clear Cell Carcinoma of the Breast: A Comprehensive Review.. Appl Immunohistochem Mol Morphol 2020;28(9):655-660. doi:10.1097/pai.0000000000000850 PubMed
  28. High-Risk Human Papillomaviruses (HPV) and Epstein - Barr virus (EBV) are Commonly Present in Rectal Cancer. 2020.
  29. Gupta I, Al Farsi H, Jabeen A, Skenderi F, Al-Thawadi H, AlAhmad YM, Abdelhafez I, Al Moustafa AE, Vranic S. High-Risk Human Papillomaviruses and Epstein–Barr Virus in Colorectal Cancer and Their Association with Clinicopathological Status. Pathogens 2020;9(6):452. doi:10.3390/pathogens9060452 PubMed
  30. Catic A, Kurtovic-Kozaric A, Sophian A, Mazur L, Skenderi F, Hes O, Rohan S, Rakheja D, Kogan J, Pins MR. KANK1-NTRK3 fusions define a subset of BRAF mutation negative renal metanephric adenomas. BMC Med Genet 2020;21(1):202. doi:10.1186/s12881-020-01143-6 PubMed
  31. Molecular Profiling of Clear Cell Carcinoma of the Breast Reveals Novel Targetable Biomarkers. 2020.
  32. Vranic S, Stafford P, Palazzo J, Skenderi F, Swensen J, Xiu J, Spetzler D, Gatalica Z. Molecular Profiling of the Metaplastic Spindle Cell Carcinoma of the Breast Reveals Potentially Targetable Biomarkers.. Clinical Breast Cancer 2020;20(4):326-331.e1. doi:10.1016/j.clbc.2020.02.008 PubMed
  33. Skenderi F, Palazzo J, Swensen J, Feldman R, Contreras E, Florento E, Gatalica Z, Vranic S. Novel targetable biomarkers in clear cell carcinoma of the breast uncovered by molecular profiling: A study of nine cases.. Breast J 2020;26(9):1781-1783. doi:10.1111/tbj.13842 PubMed
  34. Moran CA, Lindholm KE, Brunnström H, Langman G, Jang SJ, Spagnolo D, Chai SM, Laycock A, Falconieri G, Pizzolitto S, de Pellegrin A, Medeiros F, Edmunds L, Catarino A, Cunha F, et al.. Typical and atypical carcinoid tumors of the lung: a clinicopathological correlation of 783 cases with emphasis on histological features.. Human Pathology 2020;98:98-109. doi:10.1016/j.humpath.2020.02.005 PubMed
  35. Karin‐Kujundzic V, Kardum V, Sola IM, Paic F, Skrtic A, Skenderi F, Serman A, Nikuseva‐Martic T, Vranic S, Serman L. Dishevelled family proteins in serous ovarian carcinomas: a clinicopathologic and molecular study.. APMIS 2020;128(3):201-210. doi:10.1111/apm.13012 PubMed
  36. Beslija S, Ceric T, Hasanbegovic B, Skenderi F, Alidžanović J, Kopric D, Marjanović I, Mekic-Abazovic A, Sisic I, Hammami M, Pasic A, Rasic A, Kapisazović E. effects of delayed initiation of adjuvant trastuzumab for non metastatic her2 positive breast cancer in a limited resources setting ml25232 study final results. Annals of Oncology 2019;30:v68. doi:10.1093/annonc/mdz240.025
  37. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. letter to the editor response. Breast J 2019;25(3):569-569. doi:10.1111/tbj.13284 PubMed
  38. Dzinic SH, Mahdi Z, Bernardo MM, Vranic S, Beydoun H, Nahra N, Alijagic A, Harajli D, Pang A, Saliganan DM, Rahman AM, Skenderi F, Hasanbegovic B, Dyson G, Beydoun R, et al.. maspin differential expression patterns as a potential marker for targeted screening of esophageal adenocarcinoma gastroesophageal junction adenocarcinoma. PLoS ONE 2019;14(4):e0215089. doi:10.1371/journal.pone.0215089 PubMed
  39. Alaghehbandan R, Ulamec M, Martinek P, Pivovarcikova K, Michalova K, Skenderi F, Hora M, Michal M, Hes O. papillary pattern in clear cell renal cell carcinoma clinicopathologic morphologic immunohistochemical and molecular genetic analysis of 23 cases. Annals of Diagnostic Pathology 2019;38:80-86. doi:10.1016/j.anndiagpath.2018.11.004 PubMed
  40. Terlević R, Perić Balja M, Tomas D, Skenderi F, Krušlin B, Vranic S, Demirović A. Somatostatin receptor SSTR2A and SSTR5 expression in neuroendocrine breast cancer. Annals of Diagnostic Pathology 2019;38:62-66. doi:10.1016/j.anndiagpath.2018.11.002 PubMed
  41. Gatalica Z, Vranic S, Stafford P, Palazzo J, Skenderi F, Swensen J, Xiu J, Spetzler D. spindle cell carcinoma of the breast rare cancer with potentially targetable biomarkers. Annals of Oncology 2019;30:iii19. doi:10.1093/annonc/mdz095.057
  42. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. 115 (PB-016) Clinicopathologic characteristics of invasive apocrine carcinoma of the breast: A single center experience from a country with limited resources. European Journal of Cancer 2018;92:S24. doi:10.1016/s0959-8049(18)30298-3
  43. Catic A, Kurtovic-Kozaric A, Sophian A, Mazur L, Skenderi F, Hes O, Rohan S, Rakheja D, Kogan J, Pins MR. 23. Prevalence of KANK1-NTRK3 fusion in renal metanephric adenomas that lack BRAF mutations. Cancer Genetics 2018;224-225:59. doi:10.1016/j.cancergen.2018.04.026
  44. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. A clinicopathologic study of invasive apocrine carcinoma of the breast: A single-center experience.. Breast J 2018;24(6):1105-1108. doi:10.1111/tbj.13140 PubMed
  45. AlAhmad YM, Abdelhafez I, Cyprian FS, Skenderi F, Akhtar S, Vranic S. A Critical Appraisal of Predatory Journals in Pathology. 2018. doi:10.1101/482174
  46. Karin V, Skrtic A, Skenderi F, Ibisevic N, Vranic S, Serman L. dna promoter methylation status and protein expression of shh and ihh in serous ovarian carcinomas. Annals of Oncology 2018;29:iii14. doi:10.1093/annonc/mdy047.016
  47. Beslija S, Pasic A, Kapisazovic E, Hasanbegovic B, Sokolovic E, Skenderi F, Ceric T. neoadjuvant trastuzumab pertuzumab in her2 positive breast cancer in a country with limited resources evaluation of complete pathological response in a real world practice. JCO 2018;36(15_suppl):e12661-e12661. doi:10.1200/jco.2018.36.15_suppl.e12661
  48. Petersson F, Martinek P, Vanecek T, Pivovarcikova K, Peckova K, Ondic O, Perez-Montiel D, Skenderi F, Ulamec M, Nenutil R, Hora M, Svoboda T, Rotterova P, Dusek M, Michal M, et al.. renal cell carcinoma with leiomyomatous stroma a group of tumors with indistinguishable histopathologic features but 2 distinct genetic profiles next generation sequencing analysis of 6 cases negative for aberrations related to the vhl gene. Appl Immunohistochem Mol Morphol 2018;26(3):192-197. doi:10.1097/pai.0000000000000410 PubMed
  49. Skenderi F. Review of Gynecologic and Breast Pathology. 2018. doi:10.5005/jp/books/14231
  50. Peckova K, Martinek P, Pivovarcikova K, Vanecek T, Alaghehbandan R, Prochazkova K, Montiel DP, Hora M, Skenderi F, Ulamec M, Rotterova P, Daum O, Ferda J, Davidson W, Ondic O, et al.. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology, immunohistochemical, and molecular-genetic profile of 10 cases.. Annals of Diagnostic Pathology 2017;26:23-30. doi:10.1016/j.anndiagpath.2016.10.007 PubMed
  51. Kardum V, Karin V, Glibo M, Skrtic A, Martic TN, Ibisevic N, Skenderi F, Vranic S, Serman L. Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas. Annals of Diagnostic Pathology 2017;31:45-49. doi:10.1016/j.anndiagpath.2017.07.002 PubMed
  52. Skenderi F, Ulamec M, Vanecek T, Martinek P, Alaghehbandan R, Foix MP, Babankova I, Montiel DP, Alvarado-Cabrero I, Svajdler M, Dubinský P, Cempirkova D, Pavlovsky M, Vranic S, Daum O, et al.. Warthin-like papillary renal cell carcinoma: Clinicopathologic, morphologic, immunohistochemical and molecular genetic analysis of 11 cases. Annals of Diagnostic Pathology 2017;27:48-56. doi:10.1016/j.anndiagpath.2017.01.005 PubMed
  53. Michal M, Kazakov DV, Agaimy A, Hosova M, Michalova K, Grossmann P, Steiner P, Skenderi F, Vranic S, Michal M. Whorling cellular perineurioma: A previously undescribed variant closely mimicking monophasic fibrous synovial sarcoma. Annals of Diagnostic Pathology 2017;27:74-78. doi:10.1016/j.anndiagpath.2017.02.001 PubMed
  54. Skenderi F. Breast cancer incidence, demographic, and pathological characteristics in Bosnia and Herzegovina. 2016. doi:10.26226/morressier.578f37fbd462b8028d88f19c
  55. Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova K, Rotterova P, Kokoskova B, Trpkov K, Vesela P, Hora M, Kalusova K, Sperga M, Perez Montiel D, Alvarado Cabrero I, Bulimbasic S, et al.. Cystic Renal Oncocytoma and Tubulocystic Renal Cell Carcinoma. Appl Immunohistochem Mol Morphol 2016;24(2):112-119. doi:10.1097/pai.0000000000000156 PubMed
  56. Redzepagic J, Skenderi F, Bajrovic J, Beslagic V, Ibisevic N, Vranic S. Low-grade malignant peripheral nerve sheath tumor: a report of the first case in the breast and literature review. APMIS 2016;124(5):428-430. doi:10.1111/apm.12515 PubMed
  57. Damjanov I, Skenderi F, Vranic S. Mammary Analogue Secretory Carcinoma (MASC) of the salivary gland: A new tumor entity. Biomol Biomed 2016;16(3):237-238. doi:10.17305/bjbms.2016.1321 PubMed
  58. Foix MP, Dunatov A, Martinek P, Mundó EC, Suster S, Sperga M, Lopez JI, Ulamec M, Bulimbasic S, Montiel DP, Alaghehbandan R, Peckova K, Pivovarcikova K, Ondrej D, Rotterova P, et al.. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant. Virchows Arch 2016;469(6):669-678. doi:10.1007/s00428-016-2022-x PubMed
  59. Foix MP, Dunatov A, Martinek P, Mundó EC, Suster S, Sperga M, Lopez JI, Ulamec M, Bulimbasic S, Montiel DP, Alaghehbandan R, Peckova K, Pivovarcikova K, Ondrej D, Rotterova P, et al.. Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.. Virchows Arch 2016;469(6):669-678. PubMed
  60. Skenderi F, Chikha A, Ibisevic N, Tatarevic-Suko A, Kantardzic N, Vranic S. Skeletal Muscle Metastases from Squamous Cell Carcinoma of the Cervix. Int J Gynecol Pathol 2017;36(1):95-100. doi:10.1097/pgp.0000000000000298 PubMed
  61. Ulamec M, Skenderi F, Trpkov K, Kruslin B, Vranic S, Bulimbasic S, Trivunic S, Montiel DP, Peckova K, Pivovarcikova K, Ondic O, Daum O, Rotterova P, Dusek M, Hora M, et al.. Solid papillary renal cell carcinoma: clinicopathologic, morphologic, and immunohistochemical analysis of 10 cases and review of the literature. Annals of Diagnostic Pathology 2016;23:51-57. doi:10.1016/j.anndiagpath.2016.04.008 PubMed
  62. Fabijanovic D, Zunic I, Martic TN, Skenderi F, Serman L, Vranic S. The expression of SFRP1, SFRP3, DVL1, and DVL2 proteins in testicular germ cell tumors. APMIS 2016;124(11):942-949. doi:10.1111/apm.12588 PubMed
  63. Skenderi F. The members of Wnt pathway SFRP1, SFRP3, and DVL1 are downregulated in testicular germ cell tumours. 2016. doi:10.26226/morressier.578f37ffd462b8028d890688
  64. Pivovarcikova K, Peckova K, Martinek P, Montiel DP, Kalusova K, Pitra T, Hora M, Skenderi F, Ulamec M, Daum O, Rotterova P, Ondic O, Dubova M, Curik R, Dunatov A, et al.. “Mucin”-secreting papillary renal cell carcinoma: clinicopathological, immunohistochemical, and molecular genetic analysis of seven cases. Virchows Arch 2016;469(1):71-80. doi:10.1007/s00428-016-1936-7 PubMed
  65. Damjanov I, Vranic S, Skenderi F. Does everything a surgeon takes out have to be seen by a pathologist? A review of the current pathology practice. Virchows Arch 2015;468(1):69-74. doi:10.1007/s00428-015-1801-0 PubMed
  66. Ulamec M, Skenderi F, Zhou M, Krušlin B, Martínek P, Grossmann P, Peckova K, Alvarado-Cabrero I, Kalusova K, Kokoskova B, Rotterova P, Hora M, Daum O, Dubova M, Bauleth K, et al.. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern. Appl Immunohistochem Mol Morphol 2016;24(7):521-530. doi:10.1097/pai.0000000000000213 PubMed
  67. Skenderi F, Vranic S, Damjanov I. Regulated cell death in diagnostic histopathology. Int. J. Dev. Biol. 2015;59(1-2-3):149-158. doi:10.1387/ijdb.150037fs PubMed
  68. Sarcomatoid variant of urothelial carcinoma of the urinary bladder: A study of 27 cases. Virchows Archiv 2015.
  69. Skenderi F, Krakonja F, Vranic S. Infarcted fibroadenoma of the breast: Report of two new cases with review of the literature. Diagn Pathol 2013;8(1):38. doi:10.1186/1746-1596-8-38 PubMed
  70. Udovčić Gagula D, Skenderi F, Gornjaković S, Ibišević N, Chikha A, Vranić S, Ðuran A. Uterine cervix squamous cell carcinoma metastatic to the Ampulla of Vater: a case report with review of the literature. JHSCI 2013;3(2):173-176. doi:10.17532/jhsci.2013.84
  71. Infarcted fibroadenoma of the breast: report of two cases. Histopathology 2012.
  72. Viral vaccines and vectors - Some lessons from cytomegaloviruses. Periodicum Biologorum 2012.
  73. First decade of publishing Bosnian Journal of Basic Medical Sciences.. Bosnian journal of basic medical sciences 2011.
  74. Kiseljaković E, Jadrić R, Hasić S, Skenderi F, Resić H, Winterhalter-Jadrić M. Polymorphism in Methylentetrahydrofolate Reductase Gene: Important Role in Diseases. Biomol Biomed 2008;8(2):165-169. doi:10.17305/bjbms.2008.2975 PubMed

Conference papers

  1. Tomić K, Pedersen S, Skenderi F, Ibišević N, Karan Križanac D, Vrdoljak E, Berić Jozić G, Pezer Naletilić M, HonoréB, Vranic S. Proteomic profiling and correlation with clinicopathological characteristics of patients with small cell lung cancer: a pilot study. Libri Oncologici 2023;51(suppl.1):77-8
  2. Alaghehbandan R, Agaimy A, Ali L, Alvarado-Cabrero I, Amin MB, Boudova L, Caliò A, Comperat EM, Damjanov I, Daum O, Farcas M, Gatalica Z, Gill AJ, Hartmann A, Hayes MM, Hora M, Kojima F, Kristiansen G, Kuroda N, López JI, Maclean F, Magi-Galluzzi C, Martignoni G, McKenney JK, Michalová K, Michal M, Mohanty SK, Netto GJ, Ohashi R, Ondič O, Osunkoya AO, Gomez MDPM, Petersson F, Picken MM, Pivovarcikova K, Rogala J, Shah RB, Siadat F, Skenderi F, Sperga M, Suster SM, Svajdler M, Tretiakova M, Trpkov K, Ulamec M, Williamson SR, Yang XJ, Zhou M, Vranic S, Vujanic G, Michal M. A tribute to Prof. Ondrej Hes, MD, PhD (1968–2022). Mod Pathol (2022). https://doi.org/10.1038/s41379-022-01159-8
  3. Skenderi F, Alahmad MAM, Alahamd YM, Abdelhafez IHE, Gatalica Z, Vranic S. HER2-positive Apocrine Carcinoma of the Breast: A population-based Analysis of Incidence, Treatment, and Outcome. Virchows Arch 2020, suppl.,(ECP/IAP presentation, December 2020).
  4. Skenderi F, Palazzo J, Swensen J, Contreras E, Florento E, Gatalica Z, Vranic S. Molecular Profiling of Clear Cell Carcinoma of the Breast Reveals Novel Targetable Biomarkers. Mod Pathol 2020;33(suppl.2):263. (Poster#267, USCAP 2020, Los Angeles).
  5. Gupta I, Jabeen A, Skenderi F, Malki MI, Al-Thawadi H, Al Moustafa AE, Vranic S. High-risk Human Papillomaviruses (HPV) and Epstein – Barr virus (EBV) are Commonly Present in Rectal Cancer. Mod Pathol 2020;33(suppl.2):676. (Poster#683, USCAP 2020, Los Angeles).
  6. S Beslija, T Ceric, B Hasanbegovic, F Skenderi, J Alidžanović, D Kopric, I Marjanović, A Mekic-Abazovic, IS Sisic, M Hammami, A Pasic, A Rasic, E Kapisazović. Effects of delayed initiation of adjuvant trastuzumab for non-metastatic, HER2 positive breast cancer in a limited resources setting: ML25232 study final results. Annals of Oncology 2019;30(supp5):v68 https://doi.org/10.1093/annonc/mdz240.025.
  7. Gatalica S, Vranic S, Stafford P, Skenderi F, Swensen J, Xiu J, Spetzler D. Spindle cell carcinoma of the breast: rare cancer with potentially targetable biomarkers. Ann Oncol 2019;30(suppl.3):mdz095.057, https://doi.org/10.1093/annonc/mdz095.057
  8. A Chikha, N Ibisevic, F Skenderi, S Bajramovic. Granulomatous inflammation after intravesical BCG immunotherapy for bladder cancer. Virchows Archiv 2019;475:S430-S430
  9. Chikha A, Ibisevic N, Skenderi F, Junuzovic D, Vranic S. A bilateral sex-cord stromal tumor of the testis. Report of the case. Abstractbook of Posters and Oral Presentations, XXXII Congress of the International Academy of Pathology, P-18, Abstract No. 10, Amman 2018.
  10. Ibrahim Abdelhafez, Yaman M. Alahmad, Faruk Skenderi, Semir Vranic. Predatory Journals in Oncology: A Critical Appraisal.  2nd World Congress on Undergraduate Research, Oldenburg, Germany, 2018
  11. V Karin, A Skrtic, F Skenderi, N Ibisevic, S Vranic, L Serman. DNA promoter methylation status and protein expression of SHh and IHh in serous ovarian carcinomas. Annals of Oncology, 2018;29(3).https://doi.org/10.1093/annonc/mdy047.016
  12. AlAhmad YFM, Abdelhafez IHE, Cyprian FS, Skenderi F, Akhtar S, Vranic S. Predatory journals in pathology: A comprehensive assessment. Abstractbook of Posters and Oral Presenations, XXXII Congress of the International Academy of Pathology, FOP-08-1, Abstract No. 003, Amman, 2018.
  13. Semir Beslija, Anes Pasic, Elma Kapisazovic, Berisa Hasanbegovic, Emir Sokolovic, Faruk Skenderi, Timur Ceric. Neoadjuvant trastuzumab + pertuzumab in HER2 positive breast cancer in a country with limited resources: Evaluation of complete pathological response in a real world practice. Journal of Clinical Oncology 2018 36:15_suppl, e12661-e12661.
  14. Karin V, Skrtic A, Skenderi F, Ibisevic N, Vranic S, Serman L. The status of SHH and IHH in serous ovarian carcinomas. Ann Oncol 2018;31(suppl_3):mdy047.016. (TAT 2018 – Targeted Anticancer Therapies, Paris, March 2018).
  15. Karin-Kujundzic V, Kardum V, Skrtic A, Skenderi F, Vranic S, Serman L. Expression of Dishevelled family proteins DVL1, DVL2 and DVL3 in serous ovarian carcinomas. Proceedings of the 2nd Frankfurt Conference on Quality Control in Life Processes & 8th International p63/p73 Workshop, September 2-6, 2018, Proceedings, pp 112-3 (Poster P1-031)
  16. Ibisevic N, Chikha A, Humackic A, Guzin Z, Bilalovic N, Vranic S, Skenderi F.  Diagnostic performance and concordance of histological and radiological findings on breast core needle biopsy: three years’ experience. (XXXII Congress of International Academy of Pathology, Amman, 2018)
  17. Masic S, Bacalja J, Vucic M, Cupic H, Tomas D, Ulamec M, Spajic B, Skenderi F, Kruslin B. Correlation of expression of Tgf-ß, Mmp2 and Lmo2 between prostatic adenocarcinoma and adjacent unaffected parenchyma. Virchows Arch 2018, suppl., in press. (30th European Congress of Pathology, Bilbao 2018)
  18. Ulamec M, Bacalja J, Masic S, Dzombeta T, Stimac G, Tomaskovic I, Skenderi F, Kruslin B. Clefting and the expression of E-cadherin and Lmo2 in prostatic adenocarcinoma. Virchows Arch 2018, suppl., in press. (30th European Congress of Pathology, Bilbao 2018)
  19. Terlevic R, Perić Balja M, Tomas D, Kruslin B, Vranic S, Skenderi F, Demirovic A. Somatostatin receptor expression in neuroendocrine breast cancer. Virchows Arch 2018, suppl., in press. (30th European Congress of Pathology, Bilbao 2018)
  20. Semir Beslija, Anes Pasic, Elma Kapisazovic, Berisa Hasanbegovic, Emir Sokolovic, Faruk Skenderi, Timur Ceric. Neoadjuvant trastuzumab + pertuzumab in HER2 positive breast cancer in a country with limited resources: Evaluation of complete pathological response in a real world practice. Journal of Clinical Oncology 2018;36(15suppl):e12661
  21. Aida Catic, Amina Kurtovic-Kozaric, Ardis Sophian, Lech Mazur, Faruk Skenderi, Ondrej Hes, Stephen Rohan, Dinesh Rakheja, Jillene Kogan, Michael R Pins. Prevalence of KANK1-NTRK3 fusion in renal metanephric adenomas that lack BRAF mutations. Cancer Genetics 2018; 224:59
  22. AlAhmad YFM, Abdelhafez IHE, Cyprian FS, Skenderi F, Akhtar S, Vranic S. Predatory journals in pathology: A comprehensive assessment. IAP 2018 (Amman, Jordan)
  23. Karin V, Skrtic A, Skenderi F, Ibisevic N, Vranic S, Serman L. The status of SHH and IHH in serous ovarian carcinomas. Ann Oncol 2018;31(suppl_3):mdy047.016. (TAT 2018 – Targeted Anticancer Therapies, Paris, March 2018).
  24. Imamovic D, Bilalovic N, Skenderi F, Beslagic V, Ceric T, Hasanbegovic B, Beslija S, Vranic S. Clinicopathologic characteristics of invasive apocrine carcinoma of the breast: A single center experience from a country with limited resources. Eur J Cancer 2018, suppl., in press (EBCC-11, Barcelona 2018).
  25. Karin V, Kakarigi L, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Sonic Hedgehog proteins are overexpressed in high-grade serous ovarian carcinomas. Libri Oncologici 2016;44(1):38.
  26. Karin V, Kardum V, Glibo M, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas. 10th ISABS Conference on Forensic and Anthropologic Genetics and Mayo Clinic Lectures in Individualized Medicine. Dubrovnik, June 19-24, 2017.
  27. Demirović A, Vranić S, Skenderi F, Perić Balja M, Ulamec M, Vučić M, Krušlin B. Primary neuroendocrine carcinoma of the breast: a diagnostic approach to the rare primary breast malignancy. J Neuroendocrinol 2017, suppl., in press. (14th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease. 8-10 March 2017, Barcelona, Spain).
  28. Michal M, Kazakov DV, Agaimy A, Michalova K, Grossmann P, Skenderi F, Vranic S, Michal M. Whorling Cellular Perineurioma: An undescribed benign tumor mimicking monophasic fibrous synovial sarcoma. Mod Pathol 2017;30(supplement 2s):20A.
  29. Mahdi Z, Dzinic SH, Vranic S, Skenderi F, Sheng S, Beydoun R. Differential Expression and Subcellular Localization of Tumor Suppressor Maspin as a Diagnostic Marker in Gastroesophageal Junction Carcinoma and Its Precursors. Mod Pathol 2017;30(supplement 2s):185A.
  30. Karin V, Kakarigi L, Skrtic A, Nikuseva Martic T, Ibisevic N, Skenderi F, Vranic S, Serman L. Sonic Hedgehog proteins are overexpressed in high-grade serous ovarian carcinomas. Fourth Meeting of the Croatian Association for Cancer Research, November 3-4, 2016.
  31. Fabijanovic D, Zunic I, Nikuseva Martic T, Skenderi F, Serman L, Vranic S. The members of Wnt pathway SFRP1, SFRP3 and DVL1 are downregulated in testicular germ cell tumors. Virchows Arch 2016;469(suppl.1):S218-9.
  32. Skenderi F, Ibisevic N, Topcagic J, Bilalovic N, Vranic S. Breast cancer incidence, demographic, and pathological characteristics in Bosnia and Herzegovina. Virchows Arch 2016;469(suppl.1):S58.
  33. Skenderi F, Ulamec M, Vranic S, Michal M, Hes O. Warthin-like papillary renal cell carcinoma with prominent lymphocytic infiltrate: Morphologic and immunohistochemical study. Virchows Arch 2016;469(suppl.1):S14.
  34. Ibisevic N, Skenderi F, Chikha A, Bilalovic N, Vranic S. Cervical cancer incidence, demographic and pathologic characteristics in Bosnia and Herzegovina. Virchows Arch 2016;469(suppl.1):S289.
  35. Chikha A, Ibisevic N, Skenderi F, Bilalovic N, Kulovac B, Selimović M, Vranic S. Spermatocytic seminoma: Report of three cases. Virchows Arch 2016; 469(suppl.1):S236.
  36. Cesarec S, Kirgin MS, Skenderi F, Ulamec M, Stimac G, Chikha A, Vranic S, Kruslin B. Sarcomatoid variant of urothelial carcinoma of the urinary bladder. A study of 27 cases. Virchows Arch 2015;467(suppl.1):S263.
  37. Skenderi F, Ulamec M, Vranic S, Bilalovic N, Peckova K, Rotterova P, Kokoskova B, Branzovsky J, Michal M, Hes O. Cystic renal oncocytoma and tubulocystic renal cell carcinoma: Morphological and immunohistohemical study. Pathology 2014;46(S2):135-6.
  38. Chikha A, Jukovic Bihorac F, Skenderi F, Krakonja F, Bilalovic N, Vranić S. Infarcted fibroadenoma of the breast: report of two cases. Histopathology.

Books/Chapters

  1. Ivan Damjanov, Semir Vranic, Faruk Skenderi. Review of Gynecologic and Breast Pathology. Jaypee Brother Medical Publishers (P) Ltd. 2017. URL: Amazon, Book Depository, Wisepress

Other publications

  1. AlAhmad YFM, Abdelhafez IHE, Skenderi F, Vranic S. When progress becomes predation. The Pathologist 2019, https://thepathologist.com/outside-the-lab/when-progress-becomes-predation

***********

Updated: September, 2025